Neuroadrenergic dysfunction along the diabetes continuum: A comparative study in obese metabolic syndrome subjects

Diabetes

Volumn 61, Issue 10, 2012, Pages 2506-2516

  Straznicky, Nora E ^a   Grima, Mariee T ^a   Sari, Carolina I ^a   Eikelis, Nina ^a   Lambert, Elisabeth A ^a,b,c   Nestel, Paul J ^a   Esler, Murray D ^a,d   Dixon, John B ^a,d   Chopra, Reena ^a   Tilbrook, Alan J ^b   Schlaich, Markus P ^a,d   Lambert, Gavin W ^a,d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; AGE; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; AUTONOMIC NEUROPATHY; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GLUCOSE UTILIZATION; HEART BEAT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; ISOTOPE DILUTION ASSAY; MALE; METABOLIC SYNDROME X; NEUROGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 84866599217     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0138     Document Type: Article

References (53)

1. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008;32:1431-1437
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14
3. Dunstan D, Zimmet P, Welborn T, et al. Diabesity and Associated Disorders in Australia 2000. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Melbourne, Australia, Baker International Diabetes Institute, 2001, p. 5-6
4. Magliano DJ, Shaw JE, Shortreed SM, et al. Lifetime risk and projected population prevalence of diabetes. Diabetologia 2008;51:2179-2186
5. Meigs JB. The metabolic syndrome. BMJ 2003;327:61-62
6. Alberti KGMM, Eckel RH, Grundy SM, et al.; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645
7. Grassi G, Dell'Oro R, Quarti-Trevano F, et al. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 2005;48:1359-1365
8. Beske SD, Alvarez GE, Ballard TP, Davy KP. Reduced cardiovagal baroreflex gain in visceral obesity: implications for the metabolic syndrome. Am J Physiol Heart Circ Physiol 2002;282:H630-H635
9. Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab 2005;90:5998-6005
10. Esler M, Rumantir M, Wiesner G, Kaye D, Hastings J, Lambert G. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens 2001;14:304S-309S
11. Masuo K, Mikami H, Ogihara T, Tuck ML. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens 1997;10:77-83
12. Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M. Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism 2008;57:1422-1427
13. Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study, 1987-1998. Circulation 2003;107:2190-2195
14. Carnethon MR, Jacobs DR Jr, Sidney S, Liu K; CARDIA study. Influence of autonomic nervous system dysfunction on the development of type 2 diabetes: the CARDIA study. Diabetes Care 2003;26:3035-3041
15. Fiorentini A, Perciaccante A, Paris A, Serra P, Tubani L. Circadian rhythm of autonomic activity in non diabetic offsprings of type 2 diabetic patients. Cardiovasc Diabetol 2005;4:15
16. Frontoni S, Bracaglia D, Baroni A, et al. Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients. Hypertension 2003;41:1223-1227
17. Julius S, Gudbrandsson T, Jamerson K, Tariq Shahab S, Andersson O. The hemodynamic link between insulin resistance and hypertension. J Hypertens 1991;9:983-986
18. Lembo G, Capaldo B, Rendina V, et al. Acute noradrenergic activation induces insulin resistance in human skeletal muscle. Am J Physiol 1994;266:E242-E247
19. Randle PJ, Hales CN. garland PB, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;i:785-789
20. Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 1992;19:621-627
21. Vollenweider P, Randin D, Tappy L, Jéquier E, Nicod P, Scherrer U. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest 1994;93:2365-2371
22. Straznicky NE, Lambert GW, Masuo K, et al. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. Am J Clin Nutr 2009;89:27-36
23. Straznicky NE, Lambert GW, Lambert EA. Neuroadrenergic dysfunction in obesity: an overview of the effects of weight loss. Curr Opin Lipidol 2010;21:21-30
24. Golay A, Schutz Y, Felber JP, de Fronzo RA, Jéquier E. Lack of thermogenic response to glucose/insulin infusion in diabetic obese subjects. Int J Obes 1986;10:107-116
25. Huggett RJ, Scott EM, Gilbey SG, Stoker JB, Mackintosh AF, Mary DASG. Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circulation 2003;108:3097-3101
26. Tack CJJ, Smits P, Willemsen JJ, Lenders JWM, Thien T, Lutterman JA. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM. Diabetes 1996;45:15-22
27. World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of WHO/IFD Consultation. Geneva, Switzerland, World Health Organization, 2006, p. 1-46
28. Paradisi G, Smith L, Burtner C, et al. Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care 1999;22:1310-1317
29. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223
30. Eisenhofer G. Sympathetic nerve function - assessment by radioisotope dilution analysis. Clin Auton Res 2005;15:264-283
31. Eisenhofer G, Goldstein DS, Kopin IJ. Plasma dihydroxyphenylglycol for estimation of noradrenaline neuronal re-uptake in the sympathetic nervous system in vivo. Clin Sci (Lond) 1989;76:171-182
32. Herzberg-Schafer SA, Staiger H, Heni M, et al. Evaluation of fasting state-/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired β-cell function. PLoS ONE 2010;5:e14194
33. Parati G, Saul JP, Castiglioni P. Assessing arterial baroreflex control of heart rate: new perspectives. J Hypertens 2004;22:1259-1263
34. Huggett RJ, Scott EM, Gilbey SG, Bannister J, Mackintosh AF, Mary DASG. Disparity of autonomic control in type 2 diabetes mellitus. Diabetologia 2005;48:172-179
35. Jamerson KA, Smith SD, Amerena JV, Grant E, Julius S. Vasoconstriction with norepinephrine causes less forearm insulin resistance than a reflex sympathetic vasoconstriction. Hypertension 1994;23:1006-1011
36. Manrique C, Lastra G, Gardner M, Sowers JR. The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress. Med Clin North Am 2009;93:569-582
37. Ward KR, Bardgett JF, Wolfgang L, Stocker SD. Sympathetic response to insulin is mediated by melanocortin 3/4 receptors in the hypothalamic paraventricular nucleus. Hypertension 2011;57:435-441
38. Rahmouni K, Morgan DA, Morgan GM, et al. Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. J Clin Invest 2004;114:652-658
39. Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Schwartz MW. Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes 2000;49:1525-1533
40. Stein LJ, Dorsa DM, Baskin DG, Figlewicz DP, Porte D Jr, Woods SC. Reduced effect of experimental peripheral hyperinsulinemia to elevate cerebrospinal fluid insulin concentrations of obese Zucker rats. Endocrinology 1987;121:1611-1615
41. Kern W, Benedict C, Schultes B, et al. Low cerebrospinal fluid insulin levels in obese humans. Diabetologia 2006;49:2790-2792
42. Carvalheira JBC, Ribeiro EB, Araújo EP, et al. Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats. Diabetologia 2003;46:1629-1640
43. Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. J Pathol 2011;225:54-62
44. Fagius J, Berne C. The increase in sympathetic nerve activity after glucose ingestion is reduced in type I diabetes. Clin Sci (Lond) 2000;98:627-632
45. Hoffman RP, Sinkey CA, Kienzle MG, Anderson EA. Muscle sympathetic nerve activity is reduced in IDDM before overt autonomic neuropathy. Diabetes 1993;42:375-380
46. Young CN, Deo SH, Chaudhary K, Thyfault JP, Fadel PJ. Insulin enhances the gain of arterial baroreflex control of muscle sympathetic nerve activity in humans. J Physiol 2010;588:3593-3603
47. Straznicky NE, Eikelis N, Nestel PJ, et al. Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects. J Clin Endocrinol Metab 2012;97:605-613
48. Tanakaya M, Takahashi N, Takeuchi K, et al. Postprandial hypotension due to a lack of sympathetic compensation in patients with diabetes mellitus. Acta Med Okayama 2007;61:191-197
49. Figlewicz DP, Szot P, Israel PA, Payne C, Dorsa DM. Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus. Brain Res 1993;602:161-164
50. Robertson SD, Matthies HJG, Owens WA, et al. Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis. J Neurosci 2010;30:11305-11316
51. Kiyono Y, Iida Y, Kawashima H, et al. Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats. Eur J Nucl Med Mol Imaging 2002;29:999-1005
52. Nunes SF, Figueiredo IV, Pereira JS, et al. Monoamine oxidase and semicarbazide-sensitive amine oxidase kinetic analysis in mesenteric arteries of patients with type 2 diabetes. Physiol Res 2011;60:309-315
53. Lambert E, Sari CI, Dawood T, et al. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 2010;56:351-358